German biotech CureVac has canceled manufacturing contracts with two prospective partners for its Covid-19 vaccine CVnCoV while retaining others. The company said on Sept...
Lanxess and Wacker have become the first two chemical companies to join Foundation 2°, a German corporate initiative lobbying for effective market-based conditions for...
The European Chemical Industry has set out on an ambitious path to become carbon neutral. Germany, as one of the major chemical manufacturing nations, has committed to...
German chemical producer Wacker Chemie is acquiring 100% of San Diego, California- headquartered CDMO Genopis from its two South Korean owners, Helixmith and Medivate...
Germany’s Wacker Chemie is selling its remaining 30.8% stake in semiconductor specialist Siltronic to GlobalWafers. As part of the transaction, which is subject to...
Germany’s Wacker Chemie has signed a contract to manufacture the active substance for compatriot CureVac’s Covid-19 vaccine candidate CVnCoV. Under the terms, the biotech...